156 related articles for article (PubMed ID: 8991179)
1. [Late-onset multiple sclerosis and serum monoclonal gammopathy: an incidental association?].
Tréfouret S; Azulay JP; Pouget J; Boucraut J; Serratrice G
Rev Neurol (Paris); 1996; 152(8-9):554-6. PubMed ID: 8991179
[TBL] [Abstract][Full Text] [Related]
2. Unusual association of multiple sclerosis with monoclonal gammopathy of undetermined significance (MGUS): two case reports.
Rentzos M; Michalopoulou M; Gotosidis K; Caponi A; Bonakis A; Kilidireas K; Nikolaou C
Funct Neurol; 2004; 19(4):253-6. PubMed ID: 15776794
[TBL] [Abstract][Full Text] [Related]
3. [Neurological manifestations of monoclonal gammopathies].
Chassande B; Léger JM
Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
[TBL] [Abstract][Full Text] [Related]
4. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
5. Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption.
Toepfer M; Schroeder M; Müller-Felber W; Lochmüller H; Sitter T; Pongratz D; Schiffl H
Clin Nephrol; 2000 May; 53(5):404-7. PubMed ID: 11305816
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy in systemic lupus erythematosus.
Ali YM; Urowitz MB; Ibanez D; Gladman DD
Lupus; 2007; 16(6):426-9. PubMed ID: 17664233
[TBL] [Abstract][Full Text] [Related]
7. Induction of neutralizing autoantibodies to interferon-gamma in patients with polyneuropathy.
Elkarim RA; Mustafa M; Link H; Bakhiet M; Ekerfelt C; Vrethem M; Ernerudh J
Hum Antibodies; 1999; 9(1):55-60. PubMed ID: 10331186
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy associated with multiple sclerosis.
Tsung SH
Ann Clin Lab Sci; 1978; 8(6):472-5. PubMed ID: 736511
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between the IgG oligoclonal pattern and the benign nature of monoclonal abnormalities in the aged subject].
Essakalli-Gharbi M; Abbal M; Tkaczuk J; Legrand MF; Adoue D; Ohayon E
Pathol Biol (Paris); 1988 Feb; 36(2):133-8. PubMed ID: 3279380
[TBL] [Abstract][Full Text] [Related]
10. Demyelinating disease in monoclonal gammopathy of undetermined significance.
Galiè E; Pietrangeli A; Maschio M; Pace A; Vidiri A; Carosi M; Jandolo B
J Exp Clin Cancer Res; 2003 Jun; 22(2):337-9. PubMed ID: 12866587
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism and monoclonal gammopathy.
Rao DS; Antonelli R; Kane KR; Kuhn JE; Hetnal C
Henry Ford Hosp Med J; 1991; 39(1):41-4. PubMed ID: 1856101
[TBL] [Abstract][Full Text] [Related]
12. [Life-long observation of 21 patients with the M component in the serum].
Nørgaard O
Ugeskr Laeger; 1986 Oct; 148(43):2761-2. PubMed ID: 3787793
[No Abstract] [Full Text] [Related]
13. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
14. [Late onset multiple sclerosis].
Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
[TBL] [Abstract][Full Text] [Related]
15. Pseudohyperphosphataemia and monoclonal gammopathy.
Larner AJ
Br J Clin Pract; 1994; 48(5):272-4. PubMed ID: 7917825
[No Abstract] [Full Text] [Related]
16. [Diagnostic studies of cerebrospinal fluid in patients with multiple sclerosis].
Seres E; Bencsik K; Rajda C; Vécsei L
Orv Hetil; 1998 Aug; 139(32):1905-8. PubMed ID: 9731446
[TBL] [Abstract][Full Text] [Related]
17. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
[TBL] [Abstract][Full Text] [Related]
18. [Thoracic changes in multiple myeloma and monoclonal gammopathy].
Załeska J; Figura-Chojak E; Lesiak B; Wasowska H
Pneumonol Pol; 1985; 53(11-12):546-53. PubMed ID: 3834409
[No Abstract] [Full Text] [Related]
19. Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.
Rossi D; De Paoli L; Franceschetti S; Capello D; Vendramin C; Lunghi M; Conconi A; Magnani C; Gaidano G
Br J Haematol; 2007 Jul; 138(2):249-52. PubMed ID: 17535272
[TBL] [Abstract][Full Text] [Related]
20. [Normolipemic plane xanthoma, monoclonal gammopathy, anti-lipoprotein activity, hypocomplementemia].
Modiano P; Gillet-Terver MN; Reichert S; François-Griffaton A; Beaumont JL; Weber M; Schmutz JL
Ann Dermatol Venereol; 1995; 122(8):507-8. PubMed ID: 8572487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
